Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Liabilities from Discontinued Operations (2020 - 2022)

Integra Lifesciences Holdings (IART) has disclosed Liabilities from Discontinued Operations for 3 consecutive years, with 2303000.0 as the latest value for Q2 2022.

  • Quarterly Liabilities from Discontinued Operations changed N/A to 2303000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was 2303000.0 through Jun 2022, changed N/A year-over-year, with the annual reading at 11751000.0 for FY2020, N/A changed from the prior year.
  • Liabilities from Discontinued Operations hit 2303000.0 in Q2 2022 for Integra Lifesciences Holdings, down from 11751000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 12349000.0 in Q3 2020 to a low of 2303000.0 in Q2 2022.